Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-13

Clinical Trial Update: Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing lormetazepam and midazolam as sedatives for ICU patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lormetazepam (lormetazepam)
  • Midazolam (Midazolam)

Snippet

Sponsor: Claudia Spies | Conditions: Sedation in Intensive Care Unit Patients | Phase 4 | Status: COMPLETED